GERN Geron Corp

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.

$1.33  -0.05 (-3.62%)
As of 12/03/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/20/2001
Outstanding shares:  321,949,041
Average volume:  1,891,180
Market cap:   $444,289,677
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    374163103
ISIN:        US3741631036
Sedol:      2370381
Valuation   (See tab for details)
PE ratio:   -3.97
PB ratio:   2.81
PS ratio:   0.00
Return on equity:   -71.18%
Net income %:   -26,769.73%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy